1. Industry Symposium 1

    Navigating the Course of Advanced Ovarian Cancer Maintenance Therapy with Current and Emerging Biomarkers

    organised by GSK

    Thursday, February 26, 2026 │ 12:30 – 13:30

  2. Industry Symposium 2

    Optimizing Management in PROC: From Early Diagnosis to Strategic and targeted Treatment Sequencing
    organised by AbbVie

    Thursday, February 26, 2026 │12:30 – 13:30

  3. Industry Symposium 3

    Shaping the Future of Endometrial Cancer Management: Clinical Strategies and Study Updates

    organised by MSD

    Friday, February 27, 2026 │ 11:00 – 12:00

  4. Industry Symposium 4

    PARP Inhibitors in advanced Ovarian Cancer.
    Expanding Horizons: Transforming Outcomes and Supporting Patients to Move Forward

    organised by pharma&

    Friday, February 27, 2026 │ 11:00 – 12:00

  5. Industry Symposium 5

    Evolving Strategies in Platinum-Resistant Ovarian Cancer: Bridging Evidence, Regulation, and Clinical Care

    organised by GOG/Corcept Therapeutics

    Friday, February 27, 2026 │ 13:50 – 14:50

  6. Industry Symposium 6

    From Diagnosis to Decision: Endometrial Cancer Through the Clinical Lens

    organised by AstraZeneca

    Saturday, February 28, 2026 │ 11:30 – 12:30